December 5, 2008 - NEC Display Solutions of America is available of the MultiSync MD Series high-brightness, color and grayscale flat-panel monitors, specifically designed for medical imaging applications, including radiology and Picture Archiving and Communication System (PACS).
NEC’s new offerings to the MultiSync MD Series include the 21-inch, 2-megapixel MD212MC and the 21-inch, 3-megapixel MD213MC color displays - both with front sensors; and the 21-inch, 3-megapixel MD213MG grayscale display with front sensor.
The MD212MC and MD213MC color displays follow in the footsteps of the highly successful line of medical grayscales from NEC, and join the 30-inch, 4-megapixel MD304MC color display with backlight sensor announced earlier this year.
The MD212MC, MD213MC, MD213MG and MD304MC displays can be seen at the 2008 Radiological Society of North America’s (RSNA) Annual Meeting and Conference (Booth No. 4270) from November 30 through December 5 at McCormick Place in Chicago.
NEC’s new UA-SFT LCD module technology offers high brightness without compromising contrast or viewing angles, making the image quality outstanding for color or grayscale images. Select units include built-in front sensors for stability, as well as remote assurance of DICOM conformance.
The new displays feature:
. DICOM calibration and the X-Light Pro sensor system for maintaining a consistent image
. 12-bit lookup table (LUT) for detailed images and grayscale
. ColorComp, which reduces LCD uniformity errors and compensates for differences in color/grayscale and luminance
. Front or backlight sensors
. Full medical certifications
. 5-year limited warranty with overnight exchange service
The MD212MC and MD213MC displays will be available for December shipment with estimated street prices of $3,899 and $4,999, respectively. The MD213MG display will be available in January with an estimated street price of $4,699. The MD304MC display is available now for shipment with an estimated street price of $3,999.
For more information: www.necdisplay.com/medical
March 12, 2024 
